Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan prophylaxis for postoperative acute kidney injury in pediatric congenital heart surgery
2013-003105-25Phase 2Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of levosimendan in acute kidney failure (AKF) (2 arms), sponsored by Sahlgrenska University Hospital. Primary endpoint: Serum creatinine on postoperative day 2. Started Jul 2013; status: completed.
02
Drugs
levosimendan
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2013-003105-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003105-25.